Discover
FBRX
Forte Biosciences, Inc.
50.73
1 x 43.22
1 x 52.23
bid
ask
+
3.24
6.82%
1 @ 04:00 PM
50.08 -0.65 (1.28%)
| Ytd | 86.03% | |
| 1y | 386.39% |
49.26
day range
52.67
9.10
52 week range
52.67
| Open | 49.53 | Prev Close | 47.49 | Low | 49.26 | High | 52.67 | Mkt Cap | 704.42M |
| Vol | 927.51K | Avg Vol | 480.54K | EPS | -4.64 | P/E | -10.93 | Forward P/E | -1.04 |
| Beta | 2.85 | Short Ratio | 0.09 | Inst. Own | 54.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 24.48 | 200-d Avg | 24.22 | 1yr Est | 107.00 |
| Income Statement | |||
| Operating Expenses | 22.44M | ||
| Research and Development Expense | 20.47M | ||
| Selling, General and Administrative Expense | 1.97M | ||
| Operating Income | -22.44M | ||
| Income Tax Expense | 373.00K | ||
| Net Income | -22.14M | ||
| Net Income Common Stock | -22.14M | ||
| Net Income Common Stock (USD) | -22.14M | ||
| Consolidated Income | -22.14M | ||
| Earnings per Basic Share | -1.24 | ||
| Earnings per Basic Share (USD) | -1.24 | ||
| Earnings per Diluted Share | -1.24 | ||
| Earning Before Interest & Taxes (EBIT) | -21.76M | ||
| Earning Before Interest & Taxes (USD) | -21.76M | ||
| Weighted Average Shares | 17.84M | ||
| Weighted Average Shares Diluted | 17.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 58.22M | ||
| Cash and Equivalents (USD) | 58.22M | ||
| Current Assets | 65.11M | ||
| Property, Plant & Equipment Net | 110.00K | ||
| Total Assets | 67.22M | ||
| Current Liabilities | 23.65M | ||
| Total Liabilities | 25.12M | ||
| Accumulated Retained Earnings (Deficit) | -245.51M | ||
| Accumulated Other Comprehensive Income | -4.00K | ||
| Shareholders Equity | 42.10M | ||
| Shareholders Equity (USD) | 42.10M | ||
| Assets Non-Current | 2.11M | ||
| Liabilities Non-Current | 1.48M | ||
| Trade and Non-Trade Payables | 13.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.00K | ||
| Net Cash Flow from Financing | 74.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.73M | ||
| Issuance (Purchase) of Equity Shares | 101.00K | ||
| Net Cash Flow from Operations | -18.81M | ||
| Share Based Compensation | 3.18M | ||